Novo Holdings Galera Therapeutics, Inc. Transaction History

Novo Holdings

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.5 - $3.42 $897,552 - $1.23 Million	-359,021 Reduced 14.6%	2,100,000 $6.55 Million
Q1 2021 May 17, 2021	SELL	$8.35 - $12.39 $4.18 Million - $6.2 Million	-500,000 Reduced 16.9%	2,459,021 $21.7 Million
Q4 2020 Feb 16, 2021	SELL	$8.02 - $12.81 $3.61 Million - $5.76 Million	-450,000 Reduced 13.2%	2,959,021 $30.3 Million
Q4 2019 Feb 14, 2020	BUY	$9.13 - $13.9 $31.1 Million - $47.4 Million	3,409,021 New	3,409,021 $44.9 Million

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.